Chart - you can draw at the chart
Starting Amount
$
After
years
Dividend yield
%
Dividends reinvested
$
IsoRay, Inc.
Type
Public
Traded as AMEX: ISR
Industry healthcare
Founded 2004
Headquarters Richland, Washington
Website http://www.isoray.com

IsoRay Inc. (IsoRay) is a national isotope-based medical company. With its patented radioisotope technology, the company offers products including Cesium-131 seeds and other relevant treatment medicine for cancer and other malignant diseases. Its subsidiary, IsoRay Medical Inc., is the sole producer of Cesium-131 brachytherapy seeds. Brachytheraphy is when cancer-fighting medical radioisotopes are implanted in or around the affected tissue so to be as close to the cancer as possible. In 2006, its patented Cesium-131 brachytherapy seed technology was named as one of 2006's 100 most technologically significant products by R&D Magazine. The company has obtained clearance from the US Food and Drug Administration (FDA) for treatment for all solid tumor applications using its products. In 2010, the company was awarded under the IRS Qualifying Therapeutic Discovery Program (QTDP), which is a project of U.S. Department of Health and Human Services.

The company was founded in 2004 and is headquartered in Richland, Washington. The founder of IsoRay is Lance A. Bray. The company markets its products mainly in United States, besides, it also distributes the product, Proxcelan Cs-131 brachytherapy seeds, through partner UralDial LLC, in Russia. By cooperating with independent radiopharmacies, the company has enlarged its marketing channel and access to customers.

Investment goal date:
Dividends reinvested
IsoRay, Inc. ISR report Q1 2018
Period
Date
Adjusted Actuals EPS
GAAP EPS
Q3 2018
2018-05-12
--
--
Q2 2018
2018-02-12
--
--
Q2 2018
2018-02-09
--
--
Q1 2018
2017-11-14
-0.0300
0.0000
Q1 2018
2017-11-09
--
--
Q4 2017
2017-09-28
-0.0300
-0.0300
Q3 2017
2017-05-10
0.0000
-0.0200
Q2 2017
2017-02-08
0.0000
-0.0300
Q1 2017
2016-11-09
0.0000
-0.0300
Q4 2016
2016-09-08
-0.0300
-0.0200
Q3 2016
2016-05-10
-0.0200
-0.0200
Q2 2016
2016-02-09
0.0000
-0.0200
Q1 2016
2015-11-09
-0.0200
-0.0200
There is presents forecasts or rating agencies and recommendation for investors about this ticker
Funds
Fund Name
Ticker shares
Major Shareholders
Name Relationship
Total Shares
Holding stocks
LAVOY THOMAS C
0.3400% (183523)
ALAN / ISR /
KAUFFMAN ROBERT R
0.2100% (113802)
ALAN / ISR /
Boatwright Stephen
0.1100% (60000)
ISR /
Girard Roger
0.6800% (371034)
ISR /
Swanberg David
0.6100% (329409)
ISR /
Dunlop Michael
0.2500% (138051)
ISR /
McCormick Michael W
0.0400% (22000)
ISR /
Babcock Dwight William
0.6000% (326402)
ISR /
Smith Albert Louis
0.3600% (198101)
ISR /
Woods Lori A
0.0100% (8000)
ISR /
Vitale Philip J
0.0700% (37200)
ISR /
% ()